April 9, 2021

Nordic Nanovector ASA – Preliminary results of the repair offering

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AN...
Read more
April 9, 2021

CARISMA Therapeutics to Present Data at The American Association for Cancer Research Annual Meeting

- First study evaluating CAR-macrophages in fully immunocompetent solid tumor mouse models shows significant tumor control, increased survival, and induction of anti-tumor immunity...
Read more
April 8, 2021

Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)

BOSTON, April 08, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeu...
Read more
April 7, 2021

Strongbridge Biopharma plc Announces Publication of Diabetes Subgroup Analysis from Phase 3 SONICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome in Frontiers in Endocrinology

RECORLEV® (levoketoconazole) Treatment Demonstrates Clinically Meaningful Improvements in Cortisol Control and Clinical Benefit in Patients with Cushing’s Syndrome and Comorbid...
Read more
April 1, 2021

Fusion Pharmaceuticals Announces Closing Of Acquisition Of IPN-1087, A Small Molecule Targeting NTSR1, From Ipsen

HAMILTON, ON and BOSTON, April 1, 2021 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-g...
Read more
March 31, 2021

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Lund, Sweden, 12:00 pm CET, 31 March 2021 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in ...
Read more
March 31, 2021

Increase of number of shares and votes in Vicore Pharma

Gothenburg, March 31, 2021– Vicore Pharma Holding AB (publ)’s registered share capital and number of outstanding shares and votes have increased during the month of March 2...
Read more
March 31, 2021

Number of shares and votes in Oncopeptides

Stockholm — March 31, 2021 — Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the number of shares and votes in Oncopeptides has changed due to the exercise of war...
Read more
March 26, 2021

Nordic Nanovector ASA publishes 2020 Annual Report

Oslo, Norway, 26 March 2021 On 26 March 2021, the Board of Directors of Nordic Nanovector ASA approved the Company's financial statements for 2020. The Company's 2020...
Read more
March 25, 2021

Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results And Business Update

- FPI-1434 Phase 1 study is progressing - Recent transactions and partnerships expand and diversify Fusion's pipeline of targeted alpha therapies in development to...
Read more